Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

NCT01938430 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic HCV Infection

Interventions

DRUG: LDV/SOF
DRUG: RBV

Sponsor

Gilead Sciences